Proceedings · Session S-938 · filed October 13, 2026
Research Funding & PolicySession paper
Blume, Kalaari, Chiratae Named in Rs 7,131 Crore RDI Cohort
India's RDI Fund commits Rs 7,131 crore (~$850 million) to its first cohort of venture capital managers: Blume, Speciale Invest, Kalaari Capital and Chiratae Ventures.
By Priya Raman4 min read716 words
Summary
- Rs 7,131 crore (~$850 million at Rs 84/USD) committed to the RDI Fund's first cohort
- Four named venture capital managers: Blume, Speciale Invest, Kalaari Capital, Chiratae Ventures
- Additional managers referenced as 'others' but not enumerated in the headline
- First-cohort structure implies future tranches tied to deployment performance
- Per-manager allocations, sector mandates and deployment timelines undisclosed in available coverage
India's Research, Development and Innovation Fund has committed Rs 7,131 crore — approximately $850 million at current exchange rates — to a first cohort of venture capital managers that includes Blume, Speciale Invest, Kalaari Capital and Chiratae Ventures, according to a headline published by The Economic Times. The four firms are named explicitly in the publication's coverage; additional managers are referenced under the rubric of "others."
How large is the commitment?
The Rs 7,131 crore figure is the only headline number in the available coverage. At the prevailing rate of approximately Rs 84 per US dollar, the commitment translates to roughly $850 million deployed across the cohort. The Economic Times does not disclose the size of the underlying RDI Fund beyond the first-cohort total, nor does the headline break down individual allocations per manager. The Rs 7,131 crore figure carries administrative precision, suggesting that the commitment has moved from announcement into allocated capital.
Who are the named managers?
The Economic Times identifies four Indian venture capital firms by name. Blume, Speciale Invest, Kalaari Capital and Chiratae Ventures operate within India's early- and growth-stage investment market. The headline refers to "others" beyond the four named managers, but does not enumerate them or specify the total number of managers in the cohort. Per-manager allocations within the Rs 7,131 crore envelope remain undisclosed in the available coverage.
What does the first-cohort framing signal?
The Economic Times describes the four named firms and others as "the first cohort to receive" RDI Fund capital. The phrasing implies a phased deployment, with additional cohorts expected at later dates. The publication does not state the interval between cohorts, the criteria for selecting managers, or the total size of the RDI Fund beyond the Rs 7,131 crore first-cohort figure. The first-cohort label carries administrative weight: it signals that subsequent selections will be benchmarked against this round's deployment record.
What is the RDI Fund?
The headline refers to the vehicle as the "RDI fund." The available source coverage does not include explanatory text on the fund's structure, governance or accountability mechanisms. Researchers, technology-transfer offices and R&D managers seeking operational detail will need to consult the full Economic Times article or the issuing authority's documentation. The fund's relationship to existing Indian R&D financing instruments — including government grants, public-sector R&D budgets and corporate venture programmes — is not addressed in the headline.
What does this change for R&D managers?
For principal investigators, technology-transfer offices and institutional R&D leaders in India, the activation of the RDI Fund introduces a new capital channel for domestic research and early-stage technology companies. The named venture capital managers will, under the headline framing, deploy tranches of the Rs 7,131 crore cohort, though the publication does not specify whether the capital is structured as direct investment, fund-of-funds allocation, or another mechanism.
The Economic Times headline does not state whether the cohort allocation will favour deep-technology companies, applied research, university spinouts, or other categories. Indian research institutions and technology-transfer offices evaluating commercialisation pathways will need to monitor individual manager announcements as the cohort begins its work.
The Rs 7,131 crore figure sits within a broader pattern of Indian institutional capital deployment into domestic R&D. The activation of a cohort structure — rather than a single-window deployment — implies that subsequent tranches will be tied to measurable deployment performance from the first cohort, a feature that R&D managers tracking capital flows will need to monitor.
What remains unknown
The available coverage does not disclose per-manager allocations, sector mandates, deployment timelines, governance arrangements, or performance reporting obligations. Researchers and R&D managers should treat the Rs 7,131 crore figure as the total cohort commitment and await per-manager breakdowns from the issuing institution or follow-on coverage.
Forward outlook
The first-cohort activation of Rs 7,131 crore under the RDI Fund marks a concrete commitment of institutional capital to Indian research and technology deployment. Established domestic venture managers will execute the deployment, and researchers, technology-transfer offices and R&D leaders will need to watch for per-manager allocation details, sector mandates and deployment milestones as the first cohort begins capital deployment.
via Google News: R&D funding (Source)
Filed under
- rdi-fund
- india
- venture-capital
- research-funding
- technology-commercialization
More from Priya Raman
Show full bio
Staff writer covering money, funding and market shifts around research and development at Hypothesis Wire.
188 articles